CIM
SNY icon

Chiron Investment Management’s Sanofi SNY Stock Holding History

Chiron Investment Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-420,888
Closed -$21.1M – 182
2022
Q2 		$21.1M Buy
+420,888
New +$22.3M 3.53% 8

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chiron Investment Management's SNY Position: Q3 2022 in Review

Chiron Investment Management sold out of Sanofi (SNY) in Q3 2022, closing a stake of 420,888 shares — an estimated $21.1M sold.

Chiron Investment Management first reported a position in SNY in Q2 2022 and held it in 1 quarter. The position peaked at $21.1M in Q2 2022. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Chiron Investment Management reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Chiron Investment Management sold 420,888 Sanofi shares in Q3 2022, an estimated $21.1M.
  • Chiron Investment Management first reported a position in Sanofi in Q2 2022 and held it in 1 quarter.
  • Chiron Investment Management's Sanofi position peaked at $21.1M in Q2 2022.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Chiron Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.